Baird Initiates Coverage On TransMedics Gr With Outperform Rating, Announces Price Target of $200
Baird Initiates Coverage On TransMedics Gr With Outperform Rating, Announces Price Target of $200
Baird啓動對transmedics gr的覆蓋,給予表現評級,並宣佈目標股價爲200美元
Baird analyst Joe Vruwink initiates coverage on TransMedics Gr (NASDAQ:TMDX) with a Outperform rating and announces Price Target of $200.
Baird分析師Joe Vruwink開始對transmedics Gr (納斯達克:TMDX) 進行覆蓋,並給予「Outperform」評級,宣佈目標股價爲$200。
譯文內容由第三人軟體翻譯。
以上內容僅用作資訊或教育之目的,不構成與富途相關的任何投資建議。富途竭力但無法保證上述全部內容的真實性、準確性和原創性。